StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com

Nasdaq Issues Second Delisting Determination Against CN Healthy Food Tech

CN Healthy Food Tech Group Corp. said Nasdaq issued an additional delisting determination on Nov. 9, 2026, citing information from China's securities regulator, and that trading in its stock and warrants remains halted.

What happened

CN Healthy Food Tech Group Corp. (Nasdaq: UCFI), a China-based food company, disclosed in an 8-K filed Nov. 13, 2026 that it received a letter from Nasdaq's Listing Qualifications Staff on Nov. 9, 2026 issuing an additional delisting determination for its common stock and warrants.

The company said the new determination cites Nasdaq Listing Rule 5101 and violations of rules 5205(e) and 5250(a)(1), which the filing calls the 'Misrepresentation Rules.' It is based on information from the China Securities Regulatory Commission (CSRC), including a CSRC letter to Nasdaq staff dated Oct. 30, 2026.

According to the filing, the CSRC made allegations regarding the status of the company's compliance with CSRC filing requirements, the authenticity of materials the company previously provided to Nasdaq, the company's responsiveness to CSRC inquiries, and the company's PRC counsel. The filing does not include the company's response to those allegations beyond saying it intends to present its views.

Trading in the common stock and warrants remains halted, the company said. The stock's last listed close was $5.51.

The sequence of events

The Nov. 9 letter is the second delisting determination in the matter. The company said it received a first letter from Nasdaq staff on July 16, 2026, also citing Rule 5101 and the Misrepresentation Rules.

The company appealed. By letter dated Oct. 7, 2026, a Nasdaq Hearings Panel allowed the company to keep its listing subject to conditions, and trading was scheduled to resume Oct. 19, 2026.

The company said Nasdaq staff then continued the trading halt after receiving additional information from the CSRC and requesting more information from the company.

The company may submit written information to the Hearings Panel addressing the new deficiency by Nov. 16, 2026, and said it intends to do so by that deadline.

What this means

An 8-K is the form a U.S.-listed company files with the SEC to disclose material events between quarterly and annual reports. Item 3.01 is the specific category for a notice of delisting or a failure to meet a continued listing standard — in this case, Nasdaq's written notice that it intends to remove the securities from its market.

Nasdaq Listing Rule 5101 is a broad catch-all giving the exchange authority to deny continued listing when it believes doing so protects investors and the public interest. Rules 5205(e) and 5250(a)(1) concern the accuracy of information a company gives the exchange and the exchange's process for reviewing whether a company has misrepresented facts. The filing does not spell out what specific statements Nasdaq considers misleading; it only relays the CSRC's allegations.

The listing here covers two securities: common stock (UCFI) and warrants (UCFIW). A warrant gives its holder the right, but not the obligation, to buy one share of common stock at a fixed price — here $11.50 per share — by a set expiration date. Because the stock last closed at $5.51, that $11.50 exercise price is well above the current share price, meaning the warrant is far 'out of the money': exercising it would cost substantially more than buying shares in the market.

The next step is procedural. The Hearings Panel, not the Nasdaq staff, decides whether the company stays listed, and the company has until Nov. 16 to make its written case. A panel ruling could go either way; the company's filing states explicitly that there can be no assurance the Panel will rule in its favor, that the securities will resume trading, or that they will remain listed on Nasdaq.

Sources

Information summarized by AI from the sources listed above. May contain errors — informational only, not investment advice.